Helicobacter pylori haemagglutinin protease protein, nucleic aci

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4353201, 435 6, 4352523, 435325, 530350, 5303881, 536 2432, 536 221, 536 237, C12P 1934, C12N 1500, C07K 1300, C07K 1528

Patent

active

058375023

DESCRIPTION:

BRIEF SUMMARY
The present invention relates to Helicobacter pylori (H.pylori) haemagglutinin/protease protein, nucleic acids encoding therefor and antibodies specific thereto and, in particular, to their use in the identification of H.pylori and in the diagnosis of H.pylori infection.
H.pylori (formerly Campylobacter pyloridis or C.pylori) is a spiral-shaped Gram negative microorganism which appears to live beneath the mucus layer of the stomach. Since its first isolation in 1982 H.pylori has been associated with gastric and duodenal ulcer disease and gastric cancer. H.pylori has been described as the most chronic infectious agent of man. Reviews on the state of the art include those by C. A. M. McNulty in J. Infection, 1986, 13, 107-113, C. S. Goodwin et al. in J. Clin. Pathol., 1986, 39, 353-365 and the Eurogast Study Group, Lancet, 1993, 341, 1359-1362.
The number of genes that encode proteins that are involved in the ability of H.pylori to cause disease is unknown and virulence determinants of H.pylori have so far not been identified. A number of determinants possessed by this organism have been proposed as possible pathogenic factors. For example, multiple flagella allow the microorganism to move rapidly by a corkscrew-like motion through highly viscous fluids such as the mucus layer of the gut which normally poses a barrier to bacteria en route to the gut epithelium. Also, the ability of H.pylori to produce mucinase digesting enzymes allows the organism to spread in the stomach. Microscopic studies of gastric biopsies from patients with H.pylori infection have shown the H.pylori organisms at specific sites on the gastric epithelial cells. Biochemical studies have reported the identification of haemagglutinins that allow H.pylori to adhere to these sites.
Extracellular metalloprotease enzymes are common microbial pathogenicity factors in bacteria causing disease in mammals. Zinc metalloprotease enzymes are known to have rapid substrate turnover and broad substrate profiles. Reviews on the state of the art are by Frausto da Silva J. J. R and Williams R. J. P in, The Biological Chemistry of the Elements, 1993, Clarendon Press, Oxford, Chapter 11, and Vallee, B. L. and Auld D. S., Biochemistry, 29, 5647-5659.
The zinc metalloprotease enzyme of Pseudomonas aeruginosa (also known as the elastase enzyme) has been shown to be important in the lung tissue-destructive processes caused by this organism in cystic fibrosis patients, (Bever R. A. and Iglewski B. H., J.Bacteriol., 1988, 170, 4309-4314). Similarly, the zinc metalloprotease enzyme of Vibrio cholerae (V.cholerae) (also known as the mucinase enzyme or haemagglutinin/protease (HAP) enzyme) has been shown to be important in the attachment and detachment of these organisms during the disease cholera. References on the state of the art include: Hase C. C. and Finkelstein R. A., J. Bacteriol., 1991, 173, 3311-3317; and Finkelstein R. A. et al., Infect.Immunol. 1992, 60 472-478.
We have now surprisingly found that a virulance gene almost identical to the V.cholerae hap gene, which we have termed the H.pylori hap gene, is present in the H.pylori genome. The detection of the H.pylori hap nucleic acid sequence by polymerase chain reaction (PCR) or other hybridization methods, the detection of H.pylori HAP protein epitopes by antibody detection methods, or the detection of antibodies to the H.pylori HAP protein by, for example ELISA, have utility in the diagnosis of H.pylori mediated gastroduodenal disorders in mammals.
Prior art in the diagnosis of H.pylori mediated gastric diseases include Campylobacter DNA probes capable of hybridizing H.pylori RNA (EP-A-0350205). H.pylori oligonucleotides specific for the H.pylori urease gene sequences are disclosed in WO 91/09049. Serological detection and diagnosis of H.pylori infection by serological immunoassays and detection of H.pylori antigens and antigenic fragments are disclosed in WO 89/08843, WO 89/09497 and EP-A-0329570.
It would be highly desirable to have a reliable means of detecting H.pylori DNA, RNA or antibodies directed

REFERENCES:
patent: 4965188 (1990-10-01), Mullis et al.
patent: 5234910 (1993-08-01), Cave
patent: 5403924 (1995-04-01), Cover et al.
Ho et al. Direct Polymerase Chain Reaction Test for Detection of Helicobacter pylori in Humans and Animals, J. of Clinical Microbiology, vol. 29(11), pp. 2543-2549, 1991.
Xing et al. Detection in an Enzyme Immunoassay of an Immune Response to a Recombinant Fragment of the 128 Kilodalton Protein (CagA) of Helicobacter pylori. vol. 12(10), pp. 739-745, 1993.
Smith et al. The Human Gastric Pathogen Helicobacter Pylori has a Gene Encoding an Enzyme First Classified as a Mucinase in Vibrio Cholerae, Molecular Microbiology, vol. 13(1), pp. 153-160, 1994.
"Cloning and Nucleotide Sequence of the Vibrio cholerae Hemagglutinin/Protease (HA/Protease) Gene and Construction of an HA/Proteases-Negative Strain", Journal of Bacteriology, by C.C. Hase and R.A. Finkelstein, vol. 173, No. 11, Jun. 1991, pp. 331-3317.
"Molecular Characterization and Nucleotide Sequence of the Pseudomanas aeruginosa Elastase Structural Gene", Journal of Bacteriology, by R.A. Bever and B.H. Iglewski, vol. 170, No. 9, Sep. 1988, pp. 4309-4314.
"Purification and Characterization of the Soluble Hemagglutinin (Cholera Lectin) Produced by Vibrio cholerae", Infection and Immunity, by R.A. Finkelstein and L.F. Hanne, vol. 36, No. 3, Jun. 1982, pp. 1199-1208.
Vibrio cholerae Hemagglutinin/Protease, Colonial Variation, Virulence, and Detachment, Infection and Immunity, by R.A. Finkelstein, M. Boesman-Finkelstein, Y. Chang and C.C. Hase, vol. 60, No. 2, Feb. 1992, pp. 472-478.
The human gastric pathogen Helicobacter pylori has a gene encoding an enzyme first classified as a mucinase in Vibrio cholerae, Molecular Microbiology, by A.W. Smith, B. Chahal and G.L. French, vol. 13, No. 1, 1994, pp. 153-160.
Comparison of urease gene primer sequences for PCR-based amplification assays in identifying the gastric pathogen Helicobacter pylori, Molecular and Cellular Probes, by C.R. Lopez, R.J. Owen, N. Banatvala, Y. Abdi, J.M. Hardie, G.R. Davies and R. Feldman, vol. 7, No. 6, Dec. 1993, pp. 439-446.
"Campylobacter pyloridis-associated gastritis" (Review) Journal of Infection, by Cliodna A.M. McNulty, vol. 13, No. 1, 1986, pp. 107-113.
"Campylobacter pyloridis, gastritis, and peptic ulceration" (Review article) J. J. Clin Pathol, vol. 39, 1986, pp. 353-365.
"An international association between Helicobacter pylori infection and gastric cancer", The Lancet, by The Eurogast Study Group, vol. 341, No. 8857, May 29, 1993, pp. 1359-1362.
"Zinc Coordination, Function, and Structure of Zinc Enzymes and Other Proteins", Biochemistry, by B.L. Valee and D.S. Auld, vol. 29, No. 24, Jun. 19, 1990, pp. 5647-5649.
"Zinc: Lewis acid catalysis and regulation", Chapter 11 of The Biological Chemistry of the Elements, by Frausto da Silva, J.J.R. and Williams R.J.P., 1993, pp. 299-318.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Helicobacter pylori haemagglutinin protease protein, nucleic aci does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Helicobacter pylori haemagglutinin protease protein, nucleic aci, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Helicobacter pylori haemagglutinin protease protein, nucleic aci will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-883258

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.